youtu.be/UlHn_1Fz3ck?...
youtu.be/UlHn_1Fz3ck?...
Here you will find bi-weekly updates from the scientists from across Canada that make up CIRTN-R2FIC.
Here you will find bi-weekly updates from the scientists from across Canada that make up CIRTN-R2FIC.
#Postdoc Opportunity for individuals with an interest in advancing the understanding of pancreatic islet hormones in health and #diabetes. Diverse backgrounds, skill sets and experiences are welcome!
www.bcell.org
#Postdoc Opportunity for individuals with an interest in advancing the understanding of pancreatic islet hormones in health and #diabetes. Diverse backgrounds, skill sets and experiences are welcome!
www.bcell.org
www.bcell.org/adi-datasci....
www.bcell.org/adi-datasci....
🔗 doi.org/10.1016/j.mo...
I'm very grateful to mentors, colleagues, friends, and family who have supported me along the way ❤️.
www.ualberta.ca/en/physiolog...
I'm very grateful to mentors, colleagues, friends, and family who have supported me along the way ❤️.
www.ualberta.ca/en/physiolog...
#PancSky
www.nature.com/articles/s41...
#PancSky
www.nature.com/articles/s41...
👉 Discover more: ow.ly/Cf7K50VWSRi
#HealthResearch #HealthInnovation #AcademyFellows
Huge thanks to @vallierlab.bsky.social for this long-term collaboration!👇🧵
🔗 doi.org/10.1242/dev....
Huge thanks to @vallierlab.bsky.social for this long-term collaboration!👇🧵
🔗 doi.org/10.1242/dev....
ow.ly/CWmV50VPsVt
@isscr.org @gairdnerawards.bsky.social @sickkidsvs.bsky.social
ow.ly/CWmV50VPsVt
@isscr.org @gairdnerawards.bsky.social @sickkidsvs.bsky.social
This is for a Canada Research Chair (Tier 1)🇨🇦, a position that isnt offered often when 7yr term incl full salary (+renewable)!
Please share widely when broad immunology focus. Happy to answer any dept Q & note date 👇
@umanitoba.bsky.social
This is for a Canada Research Chair (Tier 1)🇨🇦, a position that isnt offered often when 7yr term incl full salary (+renewable)!
Please share widely when broad immunology focus. Happy to answer any dept Q & note date 👇
@umanitoba.bsky.social
www.npr.org/sections/sho...
www.npr.org/sections/sho...
rdcu.be/ejIM2
This new review by @danieljdrucker.bsky.social profiles GLP-1-based medicines, discussing optimization of pharmacokinetics and tolerability, engagement of new therapeutically useful pathways and safety aspects
rdcu.be/ejIM2
This new review by @danieljdrucker.bsky.social profiles GLP-1-based medicines, discussing optimization of pharmacokinetics and tolerability, engagement of new therapeutically useful pathways and safety aspects
https://www.theglobeandmail.com/gift/aaa9fec50b2b595cc0291494fc97e4bd10e7d6945d5c457e0bfa75d42846a705/4FRDBEKLNFESVJ3ZILAS36KR7Y
https://www.theglobeandmail.com/gift/aaa9fec50b2b595cc0291494fc97e4bd10e7d6945d5c457e0bfa75d42846a705/4FRDBEKLNFESVJ3ZILAS36KR7Y